Sansone Randy A, Forbis Jeremy S, Sosa Tres
Departments of Psychiatry and Internal Medicine, Wright State University School of Medicine, Dayton, and Department of Psychiatry Education, Kettering Medical Center, Kettering (Dr Sansone); Department of Sociology, University of Dayton, Dayton (Dr Forbis); and Department of Internal Medicine, Kettering Medical Center, Kettering (Dr Sosa), Ohio.
Prim Care Companion CNS Disord. 2011;13(2). doi: 10.4088/PCC.10m01072.
In this study, we explored the comfort level of and influences upon primary care clinicians in prescribing psychotropic medications to patients with bipolar disorder.
In May 2010, we mailed a 1-page survey to a cross-sectional sample of 143 primary care clinicians in 2 large practice groups asking physicians to specify whether they prescribe psychotropic medications to bipolar patients, describe their comfort level in prescribing psychotropic medications to this patient group, indicate possible influences on their willingness to prescribe psychotropics for bipolar patients, and provide their opinion on whether or not primary care physicians should prescribe these medications to bipolar patients.
Of the 38 respondents (response rate of 26.6%), nearly two-thirds (n = 24) reported the prescription of psychotropic medications to bipolar patients in their practices. For questions related to bipolar diagnosis and treatment, the means of all responses trended toward uncomfortable, with the prescription of antipsychotics being indicated as the aspect with which respondents were least comfortable. As for factors influencing a decision to prescribe, the restricted availability of mental health services was rated as most influential. With regard to the perceived role of primary care clinicians in prescribing psychotropic medications to bipolar patients, no respondent indicated that primary care physicians should "always" prescribe, whereas approximately two-thirds indicated "rarely" or "on occasion."
While a majority of primary care clinicians prescribe psychotropic medications to patients with bipolar disorder, a majority are also understandably hesitant to do so and appear to do so in particular circumstances, most likely related to the restricted availability of mental health services.
在本研究中,我们探讨了基层医疗临床医生为双相情感障碍患者开具精神药物时的舒适度及其影响因素。
2010年5月,我们向两个大型执业团体中的143名基层医疗临床医生的横断面样本邮寄了一份1页的调查问卷,要求医生指明他们是否为双相情感障碍患者开具精神药物,描述他们为该患者群体开具精神药物时的舒适度,指出可能影响他们为双相情感障碍患者开具精神药物意愿的因素,并就基层医疗医生是否应为双相情感障碍患者开具这些药物发表意见。
在38名受访者中(回复率为26.6%),近三分之二(n = 24)报告在其执业过程中为双相情感障碍患者开具过精神药物。对于与双相情感障碍诊断和治疗相关的问题,所有回答的均值都倾向于“不舒服”,其中开具抗精神病药物被指出是受访者最不自在的方面。至于影响开具药物决定的因素,心理健康服务的可及性受限被评为最具影响力。关于基层医疗临床医生在为双相情感障碍患者开具精神药物方面的感知作用,没有受访者表示基层医疗医生应该“总是”开具,而大约三分之二的受访者表示“很少”或“偶尔”开具。
虽然大多数基层医疗临床医生会为双相情感障碍患者开具精神药物,但大多数人对此也有所犹豫,似乎是在特定情况下才这样做,很可能与心理健康服务的可及性受限有关。